<DOC>
	<DOC>NCT01998620</DOC>
	<brief_summary>This is an evaluation of adenosine methionine for treatment of chronic hepatitis b patients with cholestasis efficacy and safety of multicenter, randomized, open label clinical trial.</brief_summary>
	<brief_title>Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis</brief_title>
	<detailed_description>evaluation of adenosine methionine for treatment of chronic hepatitis b patients with cholestasis efficacy and safety</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>1. from 1865 years old 2. diagnosed as hepatitis B, previous has HBV or HBsAg(+)&gt;6 months, and now HBsAg or HBV DNA(+) 3. with intrahepatic cholestasis: meet EASL 2009 diagnoses criteria ALP&gt;1.5ULN and GGT&gt;3ULN or STB&gt;2ULN 1. liver mass, liver carcinoma 2. liver failure 3. nonhepatic diseases caused jaundice 4. obstructive jaundice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Cholestasis</keyword>
</DOC>